Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Pharmaceutical
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing...
Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting
Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as...
Algernon Pharmaceuticals Announces Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 11, 2024...
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
SCOTTSDALE, Ariz., July 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that...
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
Oncternal Therapeutics to Present in JonesTrading Healthcare Summit
SAN DIEGO, July 11, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
XRP Healthcare LLC Successfully Registers Trademark in the UAE, Strengthening Global Expansion and Legal Compliance
DUBAI, UAE, July 12, 2024 /PRNewswire/ -- XRP Healthcare LLC is proud to announce the successful registration of its trademark...
KOLON TISSUEGENE COMPLETES PATIENT DOSING IN TWO PIVOTAL US PHASE III CLINICAL TRIALS FOR TG-C
Completed patient dosing in US Phase 3 clinical trials.There will be a two-year follow-up period, followed by submission of the...
Promising Data on Transdermal Obesity Formulations Announced by Skinvisible
Results Demonstrate Significant Transdermal Performance of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Using Invisicare TechnologyLAS VEGAS, NV / ACCESSWIRE...
RFID in Pharmaceutical Market to reach USD 7.57 Bn at a CAGR of 7.5 percent by 2030- Says Stellar Market Research
PUNE, India, July 11, 2024 /PRNewswire/ -- Stellar Market Research, a global Healthcare Market research firm has published a competitive...
Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.
Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery. WILMINGTON, Del. ,...
BrightSpec Adds Commercial Firepower to its Leadership Team and Board of Directors
Industry vets Damien Fischer and Tim Germann bring decades of market experience in the life sciences and analytical tools CHARLOTTESVILLE,...
ProofPilot Announces Series C Funding
NEW YORK, July 11, 2024 /PRNewswire/ -- ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series...
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC
SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry...
Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology
End-to-end functionality helps cut skyrocketing costs of compliance & removes workflow inefficiencies The cloud-based platform demonstrates 50%+ efficiency gains across...
AcceleDev Chemical LLC Unveils New 5,000-Sq.-Ft. R&D/GMP Production Site in Cranbury, New Jersey, USA
CRANBURY, NJ / ACCESSWIRE / July 11, 2024 / AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly...
Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract – Now 12-Month Data
CARDIFF, UK / ACCESSWIRE / July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a...
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas TherapeuticsFirst instance decision on...
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial...